Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Human Immunology|December 16, 2025
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq filesMadeline C Baker, Srijit Paul, Genesis V Lewis, et al.
The Journal of Biological Chemistry|September 17, 2005
Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFXMelissa I Niesen, Aaron R Osborne, Hua Yang, et al.
Biochemical Genetics|March 25, 2026
Chemical Complementarities of Neuroblastoma Tumor-Resident TCR CDR3s and CMV Antigens are Associated with a Better OutcomeKasey L Rigby, Rahul Jain, Etienne C Gozlan, et al.
Leukemia & Lymphoma|February 24, 2021
Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival ratesTaha I Huda, Moody Mihyu, Etienne C Gozlan, et al.
Oncogene|November 20, 2019
Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade gliomaBoris I Chobrutskiy, Michelle Yeagley, Price Tipping, et al.
International Journal of Immunogenetics|December 31, 2022
TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparitiesGeorge Angelakakis, Karisa S Serraneau, Vayda R Barker, et al.
Melanoma Research|May 24, 2023
Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilitiesDeo Rei L Agnila, Taha I Huda, Rachel A Eakins, et al.
Carcinogenesis|May 17, 2023
The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and with tumor resident, adaptive immune receptor featuresJacob C Kinskey, Taha I Huda, Etienne C Gozlan, et al.
Immunology|December 11, 2019
A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival ratesBoris I Chobrutskiy, Michelle Yeagley, Andrea Diviney, et al.
Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinomaTabitha R Hudock, Vayda R Barker, Brandon J Manley, et al.
Pageof 15